XML 27 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 11 - Equity-based Compensation
3 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
11.
EQUITY-BASED COMPENSATION
 
The Amended and Restated Cable One, Inc.
2015
Omnibus Incentive Compensation Plan (the
“2015
Plan”) provides for grants of incentive stock options, non-qualified stock options, restricted stock awards, SARs, restricted stock units (“RSUs”), cash-based awards, performance-based awards, dividend equivalent units (“DEUs”), and other stock-based awards, including performance stock units and deferred stock units. Directors, officers and employees of the Company and its affiliates are eligible for grants under the
2015
Plan as part of the Company’s approach on long-term incentive compensation.
 
Restricted stock awards granted to employees are subject to service-based vesting and certain awards are also subject to performance-based vesting and generally cliff-vest on the
three
-year anniversary of the grant date or, for certain service-based awards, in
four
equal ratable installments beginning on the
first
anniversary of the grant date. SARs granted to employees vest in
four
equal ratable installments beginning on the
first
anniversary of the grant date. RSUs are generally granted to non-employee directors on the date of the Company’s annual stockholders’ meeting and vest on the earlier of the
first
anniversary of the grant date or the annual stockholders’ meeting date immediately following the grant date. In
January 2018,
certain non-employee directors who elected to defer all or a portion of their annual cash fees were granted RSU awards in lieu of such fees, and such RSUs will vest in full on the date immediately preceding the date of the
2018
annual stockholders’ meeting. The settlement of these RSUs will follow vesting, unless the director has previously elected to defer such settlement until the earliest of his or her separation from service from the Board, a date specified by the director or a change in control of the Company.
 
The
2015
Plan provides, that, subject to certain adjustments for specified corporate events, the maximum number of shares of common stock that
may
be issued under the
2015
Plan is
334,870.
At
March 31, 2018,
266,731
shares were available for issuance under the
2015
Plan.
 
Compensation expense associated with equity based awards is recognized on a straight-line basis over the vesting period, with forfeitures recognized as incurred. Equity-based compensation expense of
$2.3
million and
$2.4
million for the
three
months ended
March 31, 2018
and
2017,
respectively, was included in selling, general and administrative expenses within the condensed consolidated statements of operations and comprehensive income. The Company recognized an income tax benefit of
$2.4
million related to equity-based awards during the
three
months ended
March 31, 2018.
The deferred tax asset related to all outstanding equity-based awards was
$2.7
million as of
March 31, 2018.  
 
Restricted Stock Awards.
Restricted shares, RSUs and DEUs are collectively referred to as “restricted stock.” A summary of restricted stock activity during the
three
months ended
March 31, 2018
is as follows:
 
   
 
 
 
 
Weighted Average
 
   
 
 
 
 
Grant Date
 
   
Restricted
   
Fair Value
 
   
Stock
   
Per Share
 
Outstanding as of December 31, 2017
   
51,290
    $
472.89
 
Granted
   
11,039
    $
707.20
 
Forfeited
   
(818
)   $
595.99
 
Vested
   
(24,171
)   $
391.19
 
Outstanding as of March 31, 2018
   
37,340
    $
592.42
 
                 
Vested and unissued as of March 31, 2018
   
3,185
    $
436.93
 
 
Equity-based compensation expense for restricted stock was
$1.4
million and
$1.7
million for the
three
months ended
March 31, 2018
and
2017.
 At
March 31, 2018,
there was
$10.2
million of unrecognized compensation expense related to restricted stock, which is expected to be recognized over a weighted average period of
1.7
years.
 
Stock Appreciation Rights.
A summary of SAR activity during the
three
months ended
March 31, 2018
is as follows:
 
   
Stock
Appreciation
Rights
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Grant
Date
Fair
Value
   
Aggregate
Intrinsic
Value
(
in thousands
)
   
Weighted
Average
Remaining
Contractual
Term
(in
y
ears)
 
Outstanding as of December 31, 2017
   
102,458
    $
477.62
    $
100.91
    $
23,173
     
8.1
 
Granted
   
12,500
    $
707.17
    $
169.54
    $
-
     
9.8
 
Exercised
   
(11,157
)   $
432.23
    $
89.73
     
 
     
 
 
Forfeited
   
(2,249
)   $
422.31
    $
87.22
     
 
     
 
 
Outstanding as of March 31, 2018
   
101,552
    $
512.09
    $
110.89
    $
18,116
     
8.1
 
                                         
Vested and exercisable as of March 31, 2018
   
15,795
    $
482.94
    $
102.51
    $
3,225
     
7.8
 
 
The grant date fair value of the Company’s SARs is measured using the Black-Scholes valuation model. The weighted average inputs used in the model for grants awarded during the
three
months ended
March 31, 2018
were as follows:  
 
   
2018
 
Expected volatility
   
22.53
%
Risk-free interest rate
   
2.31
%
Expected term (in years)
   
6.25
 
Expected dividend yield
   
0.98
%
 
Equity-based compensation expense for SARs was
$0.9
million and
$0.7
million for the
three
months ended
March 31, 2018.
At
March 31, 2018,
there was
$7.9
million of unrecognized compensation expense related to SARs, which is expected to be recognized over a weighted average period of
1.3
years.